Bigbear Pharmaceutical·Medication Guide

• FDA Approves Enasidenib for Treatment of Relapsed or Refractory Acute Myeloid Leukemia with IDH2 Mut

  August 1, 2017 – The U.S. Food and Drug Administration (FDA) approved enasidenib for the treatment of adult patients with relapsed or refractory acute···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 73

• Enasidenib Side Effects Requiring Immediate Medical Attention

  In addition to the expected therapeutic effects, some adverse reactions may occur when receiving enasidenib treatment. While not all side effects will···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 72

• FDA Warns: Symptoms of Serious Blood Cell-Related Disorders Caused by Enasidenib Leukemia Drug Not B

  On November 29, 2018, the U.S. Food and Drug Administration (FDA) warned that symptoms of differentiation syndrome, a life-threatening side effect of ···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 73

• Targeted Therapy for Adult Patients with KRAS Mutations! FDA Grants Accelerated Approval to Krazati

  FDA Approval AnnouncementOn December 12, 2022, Mirati Therapeutics announced that the U.S. Food and Drug Administration (FDA) had granted accelerated ···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• New Breakthrough in KRAS-Targeted Therapy for Lung Cancer! Krazati (adagrasib) Approved by the U.S.

  FDA Approval AnnouncementOn December 12, 2022, Mirati Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted accelerated appr···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• KRAZATI Approved in the UK for KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

  Lung Cancer Epidemiology in the UKEach year, more than 43,000 people are diagnosed with lung cancer in the UK.Non-small cell lung cancer (NSCLC) is th···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• KRAZATI Receives Second FDA Approval for KRAS G12C-Mutated Colorectal Cancer

  FDA Approval AnnouncementOn June 21, Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval to KRAZATI (adagrasib) in combi···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• TAZVERIK: The First Targeted Therapy That Blocks EZH2 for Epithelioid Sarcoma and Follicular Lymphom

  Role of EZH2 in TumorigenesisEZH2 is a protein present in many human cells that helps regulate B‑cell development.Mutations in EZH2 cause hyperactivit···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• FDA Approves New Indication for EZH2 Inhibitor Tazverik (tazemetostat) for Follicular Lymphoma (FL)

  FDA Approval AnnouncementEpizyme, a biopharmaceutical company dedicated to developing novel epigenetic therapies, recently announced that the U.S. Foo···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• Oral, First-in-Class EZH2 Inhibitor Tazverik (tazemetostat) Approved in Japan for the Treatment of E

  Japan Approval AnnouncementEisai recently announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has approved Tazverik (tazemetosta···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• Japan Approves Tazverik (tazemetostat), an Innovative Drug for EZH2-Mutation-Positive Follicular Lym

  Approval AnnouncementEisai recently announced that Japan has approved the anticancer drug Tazverik (tazemetostat, 200 mg tablets) for the treatment of···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 71

• How should I take tazemetostat

  Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.You may ta···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 71

• What is tazemetostat

  Tazemetostat is used to treat advancedepithelioid sarcoma, a rare slow-growing type of soft tissuecancer. tazemetostat is used when the cancer has spr···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 71

• What other drugs will affect adagrasib

  Adagrasib can cause a serious heart problem.Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems,hig···【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70

• What should I avoid while taking adagrasib

  Follow your doctor's instructions about any restrictions on food, beverages, or activity.【Read More】

  Update: 2026-03-10Source: Haiou HealthViews: 70